Integrative proteogenomic analyses provide novel interpretations of type 1 diabetes risk loci through circulating proteins.
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes"
DOI: 10.2337/db24-0380
Abstract: Circulating proteins may be promising biomarkers or drug targets. Leveraging genome-wide association studies of type 1 diabetes (18,942 cases and 501,638 controls of European ancestry) and circulating protein abundances (10,708 European ancestry individuals), Mendelian randomization… read more here.
Keywords: type diabetes; proteogenomic analyses; provide novel; integrative proteogenomic ... See more keywords